Affordable Access

Publisher Website

Ovariectomy and adrenalectomy for treatment of metastatic cancer of the breast

Authors
Journal
The American Journal of Surgery
0002-9610
Publisher
Elsevier
Publication Date
Volume
96
Issue
4
Identifiers
DOI: 10.1016/0002-9610(58)90964-4
Disciplines
  • Medicine

Abstract

Abstract Estrogen has been proved to be a carcinogenic agent responsible for the development of many, if not all, mammary cancers. The historical development and endocrinology of the concept of temporarily controlling and effectively palliating disseminated cancer of the breast by removal of the hormone sources has been briefly outlined. At present there is no clear-cut criterion useful in selecting patients for adrenalectomy. It seems apparent that any person afflicted with disseminated cancer of the breast should be considered a candidate for this form of therapy. To the results of this therapy on 389 cases reported in the literature are added eleven more cases, in nine of which marked palliation was received. Bilateral ovariectomy and adrenalectomies are worth while operations in the palliative therapy of disseminated cancer of the breast in that they have a low operative mortality rate and prolong the useful life expectancy of nearly one-half the patients.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Ovariectomy and adrenalectomy for treatment of met...

on The American Journal of Surger... October 1958

[Bilateral adrenalectomy & ovariectomy in treatmen...

on Arquivo de patologia November 1957

[Palliative treatment of metastatic cancer of the...

on Revue française d'études cli... June 1957

[Endocrine therapy of the metastatic breast cancer...

on Acta obstétrica y ginecológi... December 1977
More articles like this..